Cargando…

Mutations in RECQL Gene Are Associated with Predisposition to Breast Cancer

The genetic cause for approximately 80% of familial breast cancer patients is unknown. Here, by sequencing the entire exomes of nine early-onset familial breast cancer patients without BRCA1/2 mutations (diagnosed with breast cancer at or before the age of 35) we found that two index cases carried a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Jie, Wang, Yuxia, Xia, Yisui, Xu, Ye, Ouyang, Tao, Li, Jinfeng, Wang, Tianfeng, Fan, Zhaoqing, Fan, Tie, Lin, Benyao, Lou, Huiqiang, Xie, Yuntao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422667/ https://www.ncbi.nlm.nih.gov/pubmed/25945795 http://dx.doi.org/10.1371/journal.pgen.1005228

Ejemplares similares

Low expression of RECQL is associated with poor prognosis in Chinese breast cancer patients
por: Xu, Huiying, et al.
Publicado: (2018)

Association between CHEK2 H371Y mutation and response to neoadjuvant chemotherapy in women with breast cancer
por: Liu, Yin, et al.
Publicado: (2015)

Predictive value of BRCA1/2 mRNA expression for response to neoadjuvant chemotherapy in BRCA‐negative breast cancers
por: Xu, Ye, et al.
Publicado: (2017)

Germline mutation in DNA‐repair genes is associated with poor survival in BRCA1/2‐negative breast cancer patients
por: Fan, Zhenhua, et al.
Publicado: (2019)

HER2 somatic mutations are associated with poor survival in HER2‐negative breast cancers
por: Wang, Tonghui, et al.
Publicado: (2017)

Comparison of Survival After Breast-Conserving Therapy vs Mastectomy Among Patients With or Without the BRCA1/2 Variant in a Large Series of Unselected Chinese Patients With Breast Cancer
por: Wan, Qiting, et al.
Publicado: (2021)

A genome-wide association study identifies WT1 variant with better response to 5-fluorouracil, pirarubicin and cyclophosphamide neoadjuvant chemotherapy in breast cancer patients
por: Wu, Lina, et al.
Publicado: (2015)

Risk of ipsilateral breast tumor recurrence and contralateral breast cancer in patients with and without TP53 variant in a large series of breast cancer patients
por: Guo, Yonghai, et al.
Publicado: (2022)

Case report: Germline RECQL mutation potentially involved in hereditary predisposition to acute leukemia
por: Yuan, Wei, et al.
Publicado: (2023)

Ultrasound as a replacement for physical examination in clinical staging of axillary lymph nodes in breast cancer patients
por: Chen, Xue, et al.
Publicado: (2019)

Impact of clinical and pathological factors on local recurrence after breast-conserving treatment: CT-based localization for a tumor bed boost yielded better local control when compared with a surgical scar
por: Wang, Lize, et al.
Publicado: (2019)

Early prediction of pathological outcomes to neoadjuvant chemotherapy in breast cancer patients using automated breast ultrasound
por: Wang, Xinguang, et al.
Publicado: (2016)

Impact of dose-dense neoadjuvant chemotherapy on pathologic response and survival for HER2-positive breast cancer patients who receive trastuzumab
por: Wang, Lize, et al.
Publicado: (2021)

Feasibility of using negative ultrasonography results of axillary lymph nodes to predict sentinel lymph node metastasis in breast cancer patients
por: Chen, Xue, et al.
Publicado: (2018)

A single-center, randomized, parallel controlled study comparing the efficacy and safety aspects of three anthracycline-based regimens as neoadjuvant chemotherapy in primary breast cancer
por: Zhou, Yijun, et al.
Publicado: (2016)

Effect of Local Versus General Anesthesia in Breast-Conserving Surgery on Cancer Recurrence and Cost
por: Gu, Chongshan, et al.
Publicado: (2022)

Impact of Sentinel Lymph Node Biopsy on Treatment Decision and Survival in Patients Aged ≥70 Years with Breast Cancer: A Retrospective Study
por: Gu, Chongshan, et al.
Publicado: (2022)

Clinical implications of germline mutations in breast cancer genes: RECQL
por: Bowden, A. Ramsay, et al.
Publicado: (2019)

Distinct prognosis of mRNA expression of the five RecQ DNA-helicase family members – RECQL, BLM, WRN, RECQL4, and RECQL5 – in patients with breast cancer
por: Zhu, Xuan, et al.
Publicado: (2018)

RECQL: a DNA helicase in breast cancer
por: Akbari, Mohammad R., et al.
Publicado: (2015)

RECQL5 at the Intersection of Replication and Transcription
por: Hamadeh, Zeid, et al.
Publicado: (2020)

The Helicase Activity of Hyperthermophilic Archaeal MCM is Enhanced at High Temperatures by Lysine Methylation
por: Xia, Yisui, et al.
Publicado: (2015)

Generation of an induced pluripotent stem cell line from an individual with a heterozygous RECQL4 mutation
por: Jewell, Brittany E., et al.
Publicado: (2018)

Exome Sequencing in a Family Identifies RECQL5 Mutation Resulting in Early Myocardial Infarction
por: Xie, Xiang, et al.
Publicado: (2016)

Human RECQL1 participates in telomere maintenance
por: Popuri, Venkateswarlu, et al.
Publicado: (2014)

Human RECQL1 participates in telomere maintenance
por: Popuri, Venkateswarlu, et al.
Publicado: (2017)

The helicase and ATPase activities of RECQL4 are compromised by mutations reported in three human patients
por: Jensen, Martin Borch, et al.
Publicado: (2012)

Chromosome alignment maintenance requires the MAP RECQL4, mutated in the Rothmund–Thomson syndrome
por: Yokoyama, Hideki, et al.
Publicado: (2019)

Human RECQL5β stimulates flap endonuclease 1
por: Speina, Elżbieta, et al.
Publicado: (2010)

Rare presentation of Rothmund-Thomson syndrome with novel compound heterozygous mutations of the RECQL4 gene()()
por: Zhang, Xinyue, et al.
Publicado: (2020)

RECON syndrome is a genome instability disorder caused by mutations in the DNA helicase RECQL1
por: Abu-Libdeh, Bassam, et al.
Publicado: (2022)

RecQL4 Helicase Amplification Is Involved in Human Breast Tumorigenesis
por: Fang, Hongbo, et al.
Publicado: (2013)

Altered RECQL5 expression in urothelial bladder carcinoma increases cellular proliferation and makes RECQL5 helicase activity a novel target for chemotherapy
por: Patterson, Karl, et al.
Publicado: (2016)

Phase III study of HR-positive/HER2-negative/lymph node-positive breast cancer non-responsive to primary chemotherapy: a randomized trial
por: Yang, Yang, et al.
Publicado: (2023)

Author Correction: Phase III study of HR-positive/HER2-negative/lymph node-positive breast cancer non-responsive to primary chemotherapy: a randomized trial
por: Yang, Yang, et al.
Publicado: (2023)

Direct Inhibition of RNA Polymerase II Transcription by RECQL5
por: Aygün, Ozan, et al.
Publicado: (2009)

Human RECQL5 participates in the removal of endogenous DNA damage
por: Tadokoro, Takashi, et al.
Publicado: (2012)

The Fate of Two Unstoppable Trains After Arriving Destination: Replisome Disassembly During DNA Replication Termination
por: Xia, Yisui
Publicado: (2021)

Upregulation of RECQL4 expression predicts poor prognosis in hepatocellular carcinoma
por: Li, Jun, et al.
Publicado: (2018)

ATP-dependent helicase activity is dispensable for the physiological functions of Recql4
por: Castillo-Tandazo, Wilson, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nn13hm47qcgo4b2lrq6rbt9nqs